Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

Parmy Olson is a Bloomberg Opinion columnist covering technology. A former reporter for the Wall Street Journal and Forbes, ...

Helion’s nuclear fusion promises have garnered the attention of Silicon Valley—and raised concerns amongst scientists wary of ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

"Trump represents an unprecedented threat to America," Altman wrote in 2016. The day after President Donald Trump returned to office, Sam Altman, the CEO of tech giant OpenAI, stood behind the ...

Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025. Then $75 per month. Complete digital access to ...

Elon Musk and OpenAI CEO Sam Altman are fighting on X about Stargate, the infrastructure project to build data centers for ...

The price of Worldcoin jumped Wednesday, leading the crypto market after OpenAI's $500 billion AI initiative was unveiled.

OpenAI CEO Sam Altman has made several predictions about where we're headed on AGI, superintelligence, agentic AI — and when we might get there.